Stock Events

Stock Events

Halberd 

$0.001900
10
+$0.00+5.56%Friday 18:10

Statistics

Day High
0.0019
Day Low
0.0019
52W High
0.002
52W Low
0.0006
Volume
100
Avg. Volume
672,059
Mkt Cap
1.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Apr 18Expected
Q2 2011
Q3 2011
Q4 2011
Q1 2012
Q2 2012
Q3 2012
Q1 2013
-0
0
0
0.01
Expected EPS
N/A
Actual EPS
-0.0002

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
2026
0Revenue
-51,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HALB. It's not an investment recommendation.
Tesla
2
TSLA
YieldMax MSTR Option Income Strategy
2
MSTY
YieldMax Ultra Option Income Strategy
2
ULTY
Gamestop
2
GME

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson operates in the pharmaceuticals and medical devices sectors, competing with Halberd's healthcare solutions.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global biopharmaceutical company that competes in the development and manufacturing of healthcare products similar to Halberd.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a leading healthcare company that develops pharmaceuticals in areas that may overlap with Halberd's interests.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company that has a competitive product lineup in the healthcare sector, potentially competing with Halberd's offerings.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotechnology firm focusing on human therapeutics, which competes with Halberd in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company, which competes with Halberd in developing novel medicines.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies, competing with Halberd in the healthcare sector.
Biogen
BIIB
Mkt Cap32.49B
Biogen is a biotechnology company specializing in therapies for neurological diseases, competing with Halberd's healthcare solutions.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals is a biotechnology company that competes with Halberd in developing and commercializing medicines.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is known for creating treatments for serious diseases, directly competing with Halberd's focus on innovative healthcare solutions.

About

Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Show More
CEO
William A. Hartman
Employees
3
Country
United States
ISIN
US4053311092

Listings

OTC Link
US
HALB

0 Comments

Share your thoughts

FAQs

What is Halberd stock price today?▼
The current price of HALB is $0.00 USD — it has increased by +5.56% in the past 24 hours. Watch Halberd stock price performance more closely on the chart.
What is Halberd stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Halberd stocks are traded under the ticker HALB.
Is Halberd stock price growing?▼
HALB stock has risen by +18.75% compared to the previous week, the month change is a -5% fall, over the last year Halberd has showed a +5.56% increase.
What is Halberd market cap?▼
Today Halberd has the market capitalization of 1.34M
What were Halberd earnings last quarter?▼
HALB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Halberd revenue for the last year?▼
Halberd revenue for the last year amounts to 0 USD.
What is Halberd net income for the last year?▼
HALB net income for the last year is -51,000 USD.
How many employees does Halberd have?▼
As of November 2, 2026, the company has 3 employees.
In which sector is Halberd located?▼
Halberd operates in the Health & Wellness sector.
When did Halberd complete a stock split?▼
Halberd has not had any recent stock splits.
Where is Halberd headquartered?▼
Halberd is headquartered in Jackson Center, United States.